NICOTINE EG 14 mg/24 h, medicated transdermal patch 28 patches in individual sachets
Active ingredients: NICOTINE
Commercialized according to BDPM
Medicated transdermal patch28 patches in individual sachetstransdermique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NICOTINE EG 14 mg/24 h, dispositif transdermique
- Pharmaceutical form
- dispositif
- Route of administration
- transdermique
- Presentation description
- 28 sachet(s) papier aluminium polyamide polyacrylonitrile de 1 dispositif(s)
- Marketing authorisation holder
- HALEON FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 May 2020
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69005619CIP73838057CIP133400938380576Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NICOTINEdispositif | 35 mg · un dispositif | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: NICOTINE 14 mg/24 h - NICOTINELL TTS 14 mg/24 h, dispositif transdermique